After-hours movers: KB Home, Progress Software, Worthington Industries and more
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Progress Software (PRGS) PT Raised to $65 at Citi
September 26, 2024 12:45 PM EDTCiti analyst Tyler Radke raised the price target on Progress Software (NASDAQ: PRGS) to $65.00 (from $60.00) while maintaining a Neutral rating.
The analyst comments "~2% YoY revenue growth surmounted ~flat YoY expectations (powered by License), underscored by steady, portfolio-wide demand, despite NRR stuck at ~99%... More
BTIG Reiterates Neutral Rating on KB Home (KBH)
September 26, 2024 5:46 AM EDTBTIG analyst Carl Reichardt Jr. reiterated a Neutral rating on KB Home (NYSE: KBH).
The analyst comments "KBH reported 3Q24 EPS of $2.04, below our $2.10 est. (consensus $2.07). The miss was driven by lower gross margins and ASP than our ests., slightly offset by lower SG&A/sales ratio and stronger deliveries than we modeled. Unit orders declined 0.4% vs. our... More
B.Riley Reiterates Buy Rating on WAVE Life Sciences (WVE)
September 25, 2024 6:24 AM EDTB.Riley analyst Madison El-Saadi reiterated a Buy rating and $11.00 price target on WAVE Life Sciences (NASDAQ: WVE).
The analyst comments "In totality, we believe results exceeded our/investor expectations (9/18 initiation) and replicated the preclinical and early clinical datasets indicative of best-in-class exon skipping profile... More
Progress Software (PRGS) PT Raised to $70 at DA Davidson
September 25, 2024 5:56 AM EDTDA Davidson analyst Lucky Schreiner raised the price target on Progress Software (NASDAQ: PRGS) to $70.00 (from $65.00) while maintaining a Buy rating.
The analyst comments "Progress delivered another good quarter highlighted by its recent announcement to acquire ShareFile. Since initiating on PRGS, we... More
Goldman Sachs Reiterates Sell Rating on Worthington Industries (WOR)
September 25, 2024 5:41 AM EDTGoldman Sachs analyst Susan Maklari reiterated a Sell rating and $43.00 price target on Worthington Industries (NYSE: WOR).
The analyst comments "WOR reported F1Q adj. EPS of $0.50, below our $0.76 estimate and FactSet consensus of $0.71. Results were driven by: 1) the adj. operating margin 538bps below our... More
